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Smyd3 (SET and MYND domain–containing protein 3) is a histone H3 lysine 4 (H3K4) 
di- and tri-methyltransferase that forms a transcriptional complex with RNA polymerase II and 
activates the transcription of oncogenes and cell cycle genes in human cancer cells. However, the 
study of Smyd3 in mammalian early embryonic development has not yet been addressed. In the 
present study, we investigated the expression pattern of Smyd3 in mouse preimplantation embryos 
and the effects of RNA interference (RNAi)-mediated Smyd3 repression on the development of 
mouse embryos. Here, we showed that Smyd3 mRNA levels increased after the 2-cell stage, peaked 
at the 4-cell stage, and gradually decreased thereafter. Moreover, in 2-cell to 8-cell embryos, 
SMYD3 staining was more intense in the nuclei than in the cytoplasm. In Smyd3-knockdown 
embryos, the percentage of inner cell mass (ICM)-derived colony formation and trophectoderm 
(TE)-derived cell attachment was significantly decreased, resulting in a reduction in the number of 
viable offspring. Furthermore, the expression of Oct4 and Cdx2 during mid-preimplantation gene 
activation was significantly decreased in Smyd3-knockdown embryos. In addition, the transcription 
levels of ICM and epiblast markers, such as Oct4, Nanog, and Sox2; of primitive endoderm markers, 




Smyd3-knockdown blastocysts. These findings indicated that SMYD3 plays an important role in 







Embryonic development in mammals is characterized by an initial preimplantation phase 3 
that serves to prepare the embryo for implantation. Transcription from the newly formed zygotic 4 
genome, known as zygotic gene activation (ZGA), begins after fertilization between the late 1-cell 5 
stage and the 2-cell stage (Latham and Schultz 2001, Li, et al. 2010, Schultz and Worrad 1995). 6 
Subsequently, mid-preimplantation gene activation (MGA) occurs during the 4- to 8-cell stages 7 
(Hamatani, et al. 2004). Both ZGA and MGA consist of new gene expression from the embryonic 8 
genome, and both steps require proper lineage commitment and differentiation. The first lineage 9 
differentiation gives rise to the inner cell mass (ICM) and trophectoderm (TE). The pluripotency of 10 
the ICM lineage is regulated by the transcription factors Oct4 (also known as Pou5f1), Nanog, and 11 
Sox2 (Avilion, et al. 2003, Mitsui, et al. 2003, Nichols, et al. 1998), and the specification and 12 
differentiation of the TE lineage is regulated by the transcription factors Cdx2 and Eomes (Russ, et 13 
al. 2000, Strumpf, et al. 2005). Prior to implantation, the ICM gives rise to the epiblast (EPI), which 14 
predominantly expresses Nanog, and the primitive endoderm (PE), which predominantly expresses 15 
Gata6 (Chazaud, et al. 2006, Rossant 2004). The EPI will eventually give rise to the fetus, while the 16 




the fetal placenta. 18 
 In general, gene expression is regulated through the transition of several epigenetic factors, 19 
including transcription factors, chromatin-remodeling factors, and some enzymes. Examples of 20 
epigenetic changes that take place during preimplantation development include DNA methylation, 21 
histone post-translational modifications, and histone variant exchange (Akiyama, et al. 2011, 22 
Hirasawa, et al. 2008, Santos, et al. 2005, Sarmento, et al. 2004). Drastic changes in many varieties 23 
of histone post-translational modifications occur during ZGA. Histone post-translational 24 
modifications are introduced in a variety of ways. Several enzymes contribute to histone 25 
methylation (Zhang and Reinberg 2001), acetylation (Sterner and Berger 2000), phosphorylation 26 
(Nowak and Corces 2004), and ubiquitination (Shilatifard 2006). With respect to methylation, 27 
modifications of lysines 4, 36, and 79 of histone H3 (referred to as H3K4, H3K36, and H3K79, 28 
respectively) are associated with transcriptional activation, whereas modifications of lysines 9 and 29 
27 of histone H3 and lysine 20 of histone H4 (referred to as H3K9, H3K27, and H4K20, 30 
respectively) are associated with transcriptional repression (Lepikhov and Walter 2004, Sarmento, 31 
et al. 2004). Except for the H3K79 methyltransferase, known as DOT1L, histone 32 
methyltransferases (HMTase) include a conserved catalytic domain called the SET domain (Feng, et 33 




encodes a protein comprising 428 amino acids and containing a SET-domain, a MYND-type zinc 35 
finger domain, and a SET-N region. SMYD3 has been reported to be capable of methylating both 36 
H3K4 and H4K5 (Hamamoto, et al. 2004, Van Aller, et al. 2012). Evidence has accumulated that 37 
SMYD3 recruits RNA polymerase II through an RNA helicase to form a transcription complex, and 38 
that it elicits its oncogenic effects by activating the transcription of downstream target genes 39 
(Hamamoto, et al. 2004, Hamamoto, et al. 2006, Liu, et al. 2007, Liu, et al. 2013). Previous reports 40 
have demonstrated that enhanced expression of SMYD3 is essential for the growth of human cancer 41 
cells (Hamamoto, et al. 2004, Hamamoto, et al. 2006), whereas the suppression of SMYD3 42 
expression leads to apoptosis and the inhibition of cell growth, migration, and invasion (Chen, et al. 43 
2007, Zou, et al. 2009). Recent studies have determined that Smyd3 plays an important role in the 44 
development of heart and skeletal muscle during zebrafish embryogenesis (Fujii, et al. 2011). 45 
However, the role of SMYD3 in mammalian early embryonic development has not been previously 46 
addressed. 47 
 Here, we examined the expression pattern of Smyd3 mRNA and the localization of 48 
SMYD3 protein in mouse preimplantation embryos, and found that siRNA-mediated knockdown of 49 
Smyd3 during early stages of embryonic development suppressed Oct4 and Cdx2 at MGA. 50 




ICM/EPI markers, e.g., Oct4, Nanog, and Sox2; of PE markers, e.g., Gata6; and of TE markers, e.g., 52 
Cdx2 and Eomes. However, the number of apoptotic cells was not increased until Day4 after 53 
outgrowth experiments (E7.5) in Smyd3-knockdown embryos. From these results, we propose that 54 
SMYD3 plays an important role in early embryonic lineage commitment through the activation of 55 
lineage-specific genes. 56 
 57 
Materials and Methods 58 
 59 
In vitro fertilization (IVF) and embryo culture 60 
IVF was performed as previously described (Suzuki, et al. 2015). Three hours after 61 
insemination, fertilized eggs were washed and cultured until embryonic day 5.5 (E5.5) in 62 
K-modified simplex optimized medium (KSOM) containing 4 mg/mL BSA under mineral oil 63 
(Sigma-Aldrich) at 37 °C, in an atmosphere of 5% CO2 in air or used for microinjection 64 
(Tsukamoto, et al. 2013) and cultured until E5.5.  65 
 66 
RNA extraction and quantitative RT-PCR (qRT-PCR) 67 




embryos were collected at 14, 28, 50, 62, 69, 90 and 122 h after hCG injection, respectively. RNA 69 
extraction and qRT-PCR were performed as described (Suzuki, et al. 2013). Total RNA from 30 70 
embryos at each stage was extracted using the TRIzol reagent (Invitrogen, Carlsbad, CA). 71 
Transcription levels were determined using three different sets of 30 embryos per stage and 72 
normalized to H2afz known as a stable reference gene for normalization of gene expression in 73 
mouse preimplantation embryos (Jeong, et al. 2005, Mamo, et al. 2007) or Gapdh; relative gene 74 
expression was analyzed using the 2-ΔΔCt method (Livak and Schmittgen 2001). All primers used for 75 
PCR are listed in Supplementary Table 1. 76 
 77 
Microinjection of siRNA 78 
Fertilized embryos transferred to KSOM were microinjected into the cytoplasm with 5–10 79 
pL of 100 µM Smyd3 siRNA (siSmyd3-1: 5’-GCAGGGUUAUCGUCAAGCUGA-3’; siSmyd3-2: 80 
5’-GUCGUGGCGUAGUCUGUGAUC-3’; RNAi Inc., Japan) between 3 and 4 h after insemination. 81 
The same amount of negative control siRNA (siControl; RNAi Inc.), which contains scrambled 82 
sequences from the siSmyd3-1 or siSmyd3-2 construct, was also microinjected as a control. To 83 
examine the developmental competency and hatching ability, embryos were observed at 50 (E1.5), 84 




embryos were harvested at either the 4- and 8-cell stages (62 and 69 h after hCG injection, 86 
respectively) for qRT-PCR and immunostaining, at the morula or blastocyst stage (98 h after hCG 87 
injection) for outgrowth experiments, or at the blastocyst stage (122 h after hCG injection) for 88 
qRT-PCR, immunostaining, and immunoblotting.  89 
 90 
Outgrowth experiment and embryo transfer 91 
Outgrowth experiments were performed using morula or blastocyst stage embryos 92 
collected 98 h after hCG injection as previously described (Yamada, et al. 2010). After culture for 4 93 
days, the percentage of blastocysts that underwent outgrowth was calculated and photographed. A 94 
portion of the embryos that reached the 2-cell stage after microinjection was transferred into the 95 
oviducts of 0.5 dpc pseudopregnant ICR female mice. These females were sacrificed at Day 19, and 96 
pups were counted. The experiment was repeated four times. 97 
 98 
Immunostaining 99 
Embryos for immunostaining were collected as described above. For SMYD3, 100 
trimethylated H3K4 (H3K4me3), and EOMES staining, embryos were fixed in 4% 101 




Tyrode’s Solution (pH 2.5). After washing three times in PBS containing 0.3% 103 
polyvinylpyrrolidone (PVP K-30, Nacalai Tesque, Kyoto, Japan) (PBS/PVP), fixed embryos were 104 
treated with 0.5% Triton X-100 (Sigma-Aldrich) in PBS for 40 min at room temperature (RT), and 105 
blocked in PBS containing 1% BSA for 1h at RT (for SMYD3 and EOMES) or 3% BSA overnight 106 
at 4 °C (for H3K4me3). Next, embryos were incubated overnight at 4 °C with a rabbit anti-SMYD3 107 
antibody (1:100 dilution, 10 µg/mL; ab16027, Abcam Ltd, Cambridge, UK) or rabbit anti-EOMES 108 
antibody (1:500 dilution, 0.4 µg/mL; ab23345, Abcam Ltd), or for 1 h at RT with a rabbit 109 
anti-H3K4me3 antibody (1:200 dilution, 2.5 µg/mL; ab8580, Abcam Ltd) in antibody dilution 110 
buffer (PBS containing 1% BSA). Embryos were washed three times in antibody dilution buffer, 111 
and then incubated with the appropriate secondary antibody diluted at 1:500 (Alexa Fluor 112 
488-conjugated goat anti-rabbit IgG or Alexa Fluor 594-conjugated goat anti rabbit IgG, Invitrogen) 113 
for 1 h at RT. Immunostaining with normal rabbit IgG (sc-2027, Santa Cruz Biotechnology, Dallas, 114 
TX) was performed as a negative control for the specificity of the anti-SMYD3 antibody. For 115 
NANOG, SOX2, and GATA6 staining, embryos were fixed, permeabilized, and blocked as 116 
previously described (Ralston and Rossant 2008). Next, embryos were incubated overnight at 4 °C 117 
with a rabbit anti-NANOG antibody (1:1000 dilution, 1 µg/mL; ab5731, Millipore, Bedford, MA), a 118 




anti-GATA6 antibody (1:1000 dilution, 0.2 µg/mL; AF1700, R & D systems, Inc., Minneapolis, 120 
MN) in blocking solution for overnight at 4 °C. Embryos were washed three times in blocking 121 
solution, and then incubated with the appropriate secondary antibody diluted at 1:750 (Alexa Fluor 122 
594-conjugated goat anti-rabbit IgG, Invitrogen) or 1:500 or 1:750 (Alexa Fluor 594-conjugated 123 
rabbit anti-goat IgG, Invitrogen) for 1 h at RT. After staining, the samples were washed three times 124 
in antibody dilution buffer or blocking solution for 15 min, and nuclei were stained in PBS 125 
containing 10 µg/mL Hoechst 33342 (Sigma-Aldrich) for 10 min at RT. Immunofluorescent 126 
staining for OCT4 and CDX2 was performed as previously described (Isaji, et al. 2013). After 127 
staining, embryos were mounted on slides in 50% glycerol/PBS and SMYD3-related signals were 128 
observed using a fluorescence microscope (BZ-X700, Keyence, Osaka, Japan) equipped with 129 
structured illumination microscopy (Gustafsson 2005, Hosny, et al. 2013). Fluorescein signals 130 
related to OCT4, CDX2, H3K4me3, NANOG, SOX2, GATA6, and EOMES were detected using 131 
fluorescence microscopy (BX50, Olympus, Tokyo, Japan). At least 20 samples were examined in 132 
each group. The numbers of ICM and TE cells were determined by counting OCT4- and 133 
CDX2-positive cells, respectively. To count the cell number and observe the localization of OCT4, 134 
CDX2, NANOG, SOX2, GATA6, and EOMES in Smyd3-knockdown embryos exposure time was 135 




by adding the numbers determined for the ICM and TE cells. 137 
 138 
Immunoblotting 139 
Immunoblotting was performed as previously described (Suzuki, et al. 2013). Total 140 
proteins from 100 embryos were extracted using SDS sample buffer/Lysis buffer (1:1). Primary 141 
antibody was used; a mouse anti-α-TUBULIN antibody (1:5000 dilution, 1.16 µg/mL; T9026; 142 
Sigma-Aldrich), a rabbit anti-SMYD3 antibody (1:100 dilution, 10 µg/mL), a rabbit anti-H3K4me3 143 
antibody (1:200 dilution, 2.5 µg/mL), a rabbit anti-OCT4 antibody (1:500 dilution, 400 ng/mL; 144 
C-10; sc-5279, Santa Cruz Biotechnology), or a mouse anti-CDX2 antibody (1:500 dilution, 100 145 
µg/mL; CDX-88; BioGenex, San Ramon, CA). Second antibody was used; an HRP-conjugated 146 
anti-mouse secondary antibody (1:2000 or 1:10000 dilution; GE Healthcare UK Ltd, Little Chalfont, 147 
UK) or an HRP-conjugated anti-rabbit secondary antibody (1:1000 or 1:2000 dilution; GE 148 
Healthcare UK Ltd) in TBS-T for 1 h at RT. The membrane was extensively washed three times 149 
with TBS-T, and then bound antibodies were detected using the Enhanced Chemiluminescence 150 
(ECL) system (GE Healthcare UK Ltd). α-TUBULIN was used as an internal control. 151 
 152 




 Apoptotic cells in embryos at E3.5, E4.5 and E5.5, and outgrowth embryos at E6.5 and 154 
E7.5 were identified with the In Situ Cell Death Detection Kit (Roche Diagnostics Corp., 155 
Indianapolis, IN) using the protocol recommended by the manufacturer. 156 
 157 
Statistical Analysis 158 
 All data were expressed as the mean ± SEM. Statistical analysis of the date was 159 
performed by analysis of variance (ANOVA) with Student’s t-test for comparing two 160 
groups. 161 
 162 
Ethical Approval for the Use of Animals 163 
All animal experiments were approved by the Animal Research Committee of Kyoto 164 









First, we revealed the expression pattern of Smyd3 mRNA and the localization of 171 
SMYD3 protein in mouse preimplantation embryos. qRT-PCR analysis of Smyd3 mRNA in 172 
preimplantation embryos indicated that the expression levels increased after the 1-cell stage, peaked 173 
at the 4-cell stage, and then slightly decreased until the blastocyst stage (Fig. 1A). Furthermore, 174 
immunostaining showed that SMYD3 dominantly localized to the nuclei from the 2-cell to the 175 
8-cell stage (Fig. 1B).  176 
 177 
Effects of Smyd3 knockdown on the development of mouse embryos 178 
 In order to investigate the role of Smyd3 in early embryonic development, we knocked 179 
down the expression of Smyd3 in mouse preimplantation embryos. Embryos injected with siRNA 180 
targeting Smyd3 (siSmyd3-1 and siSmyd3-2) were cultured until E5.5. qRT-PCR and 181 
immunoblotting showed that the reduction in the expression of Smyd3 mRNA and protein was 182 
observed at the blastocyst stage (Fig. 2A and B; Supplementary Fig. 1A). Additionally, 183 
Immunostaining showed that SMYD3 protein levels were also reduced from the 1-cell stage and 184 
continued through the blastocyst stage (Fig. 2C). Nevertheless, no differences between 185 
Smyd3-knockdown and control embryos were noted with respect to morphology or percentage of 186 




E4.5 blastocysts were counted after OCT4 (ICM) and CDX2 (TE) staining. The data demonstrated 188 
that Smyd3-knockdown blastocysts had normal numbers of cells in both populations (Fig. 3C). To 189 
examine the pluripotency of Smyd3-knockdown embryos, outgrowth experiments were performed 190 
on E3.5 embryos. In control embryos, the percentages of successful attachment and ICM-derived 191 
colony formation were 88.9% and 81.1%, respectively, while in Smyd3-knockdown embryos, the 192 
percentages were 71.4% and 45.8 %, respectively (Fig. 3D and E). In addition, to test the viability 193 
of Smyd3-knockdown embryos in vivo, siSmyd3-1-injected embryos were transferred into the 194 
oviducts of pseudopregnant mice. The percentage of offspring derived from Smyd3-knockdown 195 
embryos was significantly reduced as compared to controls (Table 1). 196 
 197 
Knockdown of Smyd3 leads to the down-regulation of linage-specific genes 198 
 In order to analyze the reasons of the defect of peri-implantation embryonic 199 
development, we performed qRT-PCR on 4- and 8-cell stage embryos for Smyd3 and early 200 
differentiation markers such as Oct4 and Cdx2. In addition, to confirm the levels of H3K4me3 in 201 
Smyd3-knockdown embryos at the 4- and 8-cell stages immunostaining was performed. The results 202 
demonstrated that the expression of Smyd3 mRNA was significantly decreased in 203 




Interestingly, the transcription of Oct4 at the 4-cell and 8-cell stages and of Cdx2 at the 8-cell stage 205 
was significantly decreased in Smyd3-knockdown embryos (Fig. 4C and D). To further investigate 206 
the influence of the reduced expression of Smyd3, Oct4, and Cdx2 at the 4- and 8-cell stages, we 207 
performed qRT-PCR on E4.5 blastocyst stage embryos for H2afz—an internal control—and 208 
lineage-specific genes, e.g., the ICM/EPI markers, Oct4, Nanog, and Sox2; the PE marker, Gata6; 209 
and the TE markers, Cdx2 and Eomes. The results demonstrated that the transcription levels of Oct4, 210 
Nanog, Sox2, Gata6, Cdx2, and Eomes were all significantly decreased in Smyd3-knockdown 211 
embryos at the blastocyst stage, while H2afz transcript levels remained unchanged (Fig. 5A; 212 
Supplementary Fig. 2A). Furthermore, the protein levels of OCT4, CDX2, NANOG, SOX2, 213 
GATA6, and EOMES were confirmed on E4.5 blastocysts. The results demonstrated that the levels 214 
of OCT4, CDX2, NANOG, SOX2, GATA6, and EOMES were significantly reduced in 215 
Smyd3-knockdown embryos at the blastocyst stage (Fig. 5B; Supplementary Fig. 2B and 3A). 216 
Additionally, global H3K4me3 levels also remained unchanged in the treated embryos at the 217 
blastocyst stage (Supplementary Fig. 3B). 218 
 219 




 Since it has been reported that Smyd3-knockdown induces apoptosis in human cancer 221 
cells (Chen, et al. 2007), we investigated the effects of Smyd3-knockdown on apoptosis in mouse 222 
peri-implantation embryos. However, there was no differences in the number of TUNEL-positive 223 




 SMYD3 methylates both H3K4 and H4K5 (Hamamoto, et al. 2004, Van Aller, et al. 2012), 228 
recruits RNA polymerase II through an RNA helicase to form a transcription complex, and elicits 229 
its oncogenic effects by activating the transcription of downstream target genes (Hamamoto, et al. 230 
2004, Hamamoto, et al. 2006, Liu, et al. 2007, Liu, et al. 2013). SMYD3 is also involved in 231 
apoptosis and the inhibition of cell growth, migration, and invasion (Xu, et al. 2006, Zou, et al. 232 
2009). Here, we observed Smyd3 mRNA expression patterns and protein localization during mouse 233 
preimplantation development, and showed that Smyd3 knockdown led to a defect in their ability to 234 
attach to a matrix and outgrowth in vitro, and to a reduction in the numbers of viable offspring, 235 
suggesting that SMYD3 has important roles during peri-implantation development. 236 




directly to their own promoter regions in embryonic stem (ES) cells (Chew, et al. 2005, 238 
Okumura-Nakanishi, et al. 2005). Oct4, Nanog, and Sox2 are reported to be regulated via the 239 
Oct4/Sox2 complex, and to form a self-reinforcing regulatory loop in ES cells (Chew, et al. 2005, 240 
Mitsui, et al. 2003, Okumura-Nakanishi, et al. 2005, Rodda, et al. 2005). In mouse preimplantation 241 
embryos, Oct4, Nanog, and Sox2 are required for the maintenance of ICM pluripotency (Avilion, et 242 
al. 2003, Mitsui, et al. 2003, Nichols, et al. 1998). Additionally, Nanog is known to negatively 243 
interact with Gata6 and both genes are known as key regulators in the establishment of EPI and PE 244 
fates, respectively (Frankenberg, et al. 2011, Kang, et al. 2013, Morris, et al. 2010, Schrode, et al. 245 
2014). Nanog deficient mouse embryos are arrested during post-implantation development due to 246 
widespread expression of Gata6 in the EPI (Frankenberg, et al. 2011, Mitsui, et al. 2003). By 247 
contrast, Gata6 deficient mouse embryos are arrested during post-implantation development due to 248 
widespread expression of Nanog in the PE (Morris, et al. 2010, Schrode, et al. 2014). In the present 249 
study, we showed that Smyd3 knockdown led to the suppression of the embryonic transcription of 250 
Oct4 from the 4-cell stages. In addition, we also showed that, in blastocysts, Smyd3 knockdown 251 
abrogates the transcription of other ICM and EPI markers, e.g., Nanog and Sox2; and of PE 252 
markers, such as Gata6. Therefore, it is possible that the lack of pluripotency genes, such as Oct4, 253 




in Smyd3-knockdown embryos, including poor outgrowth in vitro and a reduction in the numbers of 255 
viable offspring. Furthermore, Cdx2 and Eomes are reported to be essential for the specification and 256 
differentiation of TE (Russ, et al. 2000, Strumpf, et al. 2005). Cdx2-knockout embryos fail to hatch 257 
from the zona pellucida or to implant in vivo, and also fail to attach to matrix substrates in vitro, 258 
even when the zona pellucida has been removed (Strumpf, et al. 2005). In the present study, we 259 
showed that Smyd3 knockdown led to the suppression of the embryonic transcription of Cdx2 from 260 
the 8-cell stages. Additionally, we also showed that, in blastocysts, Smyd3 knockdown abrogates the 261 
transcription of TE markers, such as Eomes. Therefore, it is possible that the suppression of 262 
TE-specific genes, such as Cdx2 and Eomes, could account for a defect in their ability to attach to a 263 
matrix substrate in vitro observed in Smyd3-knockdown embryos. Furthermore, it has been reported 264 
that Smyd3-knockdown induces apoptosis in cancer (Chen, et al. 2007). In the present study, 265 
however, we showed that the number of apoptotic cells was not increased in Smyd3-knockdown 266 
embryos. Together, these observations also suggested that SMYD3 plays an important role in 267 
peri-implantation embryonic development via the activation of lineage-specific genes expression. 268 
However, we demonstrated that in Smyd3-knockdown embryos global H3K4me3 levels appeared 269 
unchanged and that developmental arrest did not occur up to the blastocyst stage, even though 270 




Smyd3 tri-methylates H3K4 and some chromatin remodeling complexes are recruited to H3K4me3 272 
(He, et al. 2005, Sims, et al. 2005). These chromatin remodeling factors are involved in an open 273 
chromatin state, which correlates with a globally permissive transcriptional state. Within this ‘loose’ 274 
chromatin state, transcription factors can bind to the promoter regions of genes and activate 275 
transcription. The decreased expression of lineage-specific genes, such as Oct4, Nanog, and Cdx2, 276 
that we observed in this study echos results obtained in Klf5-null embryos (Lin, et al. 2010) and in 277 
Hmgpi-knockdown embryos (Yamada, et al. 2010), suggesting that SMYD3 functions via these 278 
transcription factors to determine lineage specificity. Previous studies showed that MLL2, one of 279 
the H3K4 methyltransferases, affects the global H3K4me3 levels at ZGA (Andreu-Vieyra, et al. 280 
2010), and the SETD1A/SETD1B methyltransferase complex that modifies H3K4 affects the global 281 
H3K4me3 levels at MGA (Bi, et al. 2011). Additionally, previous studies demonstrated that a 282 
knockdown of SMYD3 expression leads to the selective decrease in H3K4 methylation levels on 283 
oncogene promoter regions in cancer cells (Cock-Rada, et al. 2012, Liu, et al. 2013, Medjkane, et 284 
al.). From these observations it is possible that H3K4me3 level depends on the type of 285 
methyltransferase and that SMYD3 modified H3K4 within the promoter regions of the 286 
lineage-specific genes. In addition, a recent report demonstrated that while global levels of 287 




the global levels of H4K5me, a novel chromatin target of Smyd3, do change (Van Aller, et al. 2012). 289 
This result indicates that SMYD3 is required for H4K5 methylation in cancer cells. It is also 290 
possible that SMYD3 is involved in the regulation of genes in mouse preimplantation embryos 291 
through the methylation of H4K5.  292 
In summary, our results demonstrated that Smyd3-knockdown does not have a critical 293 
effect on early embryonic development or on global H3K4me3 levels, but that it does play an 294 
important role in early embryonic lineage commitment and peri-implantation development by 295 
regulating the expression of Oct4 and Cdx2 at MGA. Accordingly, we demonstrated the importance 296 
of Smyd3 as a key regulator of lineage-specific genes in mouse preimplantation embryos. 297 
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Figure 1. Smyd3 expression and the localization of SMYD3 in preimplantation embryos. 
(A) qRT-PCR analysis of Smyd3 expression in preimplantation embryos. The expression levels at 
each developmental stage were normalized by using H2afz as an internal control. Data are 
expressed as mean ± SEM (n=3). (B) Localization of Smyd3 in mouse preimplantation embryos. 
SMYD3 (red) is detected by immunofluorescence and nuclei (blue) are stained with Hoechst dye.  
 
Figure 2. Reduction in the expression of Smyd3 mRNA and protein at the blastocyst stage. 
(A) qRT-PCR analysis of Smyd3 mRNA at the blastocyst stage in Smyd3-knockdown and control 
embryos (*p < 0.05). The expression levels were normalized by using Gapdh as an internal 
control. Data are expressed as mean ± SEM (n=3). (B) Immunoblot analysis of SMYD3 and 
α-TUBULIN in Smyd3-knockdown and control blastocyst embryos. (C) Immunostaining of 
SMYD3 protein in Smyd3-knockdown and control blastocyst embryos (red, SMYD3; blue, 
chromatin). 
 




(A) Pairs of representative photos showing the development of preimplantation embryos injected 
with either siSmyd3-1 or siControl. Embryos were photographed at 36 h after in vitro fertilization 
and 24 h intervals thereafter. (B) The percentage of development at E1.5 (≥ 2-cell), E2.5 (≥ 4-cell), 
E3.5 (≥ morula), E4.5 (≥ blastocyst), and E5.5 (≥ hatching) in Smyd3-knockdown and control 
embryos. Data are expressed as mean ± SEM (n=3). Twenty to 25 embryos were used in each 
experiment (63 and 69 embryos in total in siControl and siSmyd3-1, respectively). (C) The numbers 
of ICM and TE cells were assessed by counting OCT4-positive cells and CDX2-positive cells, 
respectively. Total embryonic cell numbers were obtained by combining the numbers of ICM and 
TE cells. Data are expressed as mean ± SEM (n=16). (D) Photographs depict representative results 
of outgrowth experiments for control and Smyd3-knockdown embryos (ICM-derived colony, 
arrowhead; trophectoderm cells, arrow). (E) The successful percentages of attachment and 
ICM-derived colony formation in Smyd3-knockdown and control embryos after 4 days in culture 
(*p < 0.05). Data are expressed as mean ± SEM (n=6). Thirteen to 83 embryos were used in each 
experiment (238 and 243 embryos in total in siControl and siSmyd3-1, respectively). 
 
Figure 4. SMYD3 regulates the expression of Oct4 and Cdx2 at MGA. 




8-cell stages (*p < 0.05). Expression levels were normalized to Gapdh as an internal control. 
Data are expressed as mean ± SEM (n=3). (B) Immunostaining of H3K4me3 in Smyd3-knockdown 
and control embryos at the 4- and 8-cell stages (red, SMYD3; green, H3K4me3; blue, chromatin). 
(C and D) qRT-PCR analysis of Oct4 mRNA and Cdx2 mRNA in Smyd3-knockdown and control 
embryos at the 4- and 8-cell stages (*p < 0.05). Data are expressed as mean ± SEM (n=3). 
 
Figure 5. The effects of Smyd3 knockdown on the expression of lineage-specific genes in 
blastocysts. 
(A) qRT-PCR analysis of the early-lineage markers Oct4, Nanog, Sox2, Cdx2, Eomes, Gata6, and 
H2afz in Smyd3-knockdown and control blastocyst embryos (*p < 0.05). The expression levels 
were normalized by using Gapdh as an internal control. Data are expressed as mean ± SEM 
(n=3). (B) Immunostaining of OCT4, CDX2, NANOG, SOX2, GATA6, and EOMES in 
Smyd3-knockdown and control blastocyst embryos (OCT4, red; CDX2, green; NANOG, red; SOX2, 
red; GATA6, red; EOMES, green; chromatin, blue). 
 
Figure 6. The effects of Smyd3-knockdown on the induction of apoptosis. 




TUNEL assay for control and Smyd3-knockdown embryos before (E3.5-E5.5) and after (E6.5-E7.5) 
outgrowth. Nuclei are stained with Hoechst dye (blue). 
 
Supplementary Figure 1.  The effects of siSmyd3-2 injection on preimplantation development.  
(A) qRT-PCR analysis of Smyd3 mRNA at the blastocyst stage in embryos injected with either 
siSmyd3-2 or siControl (*p < 0.05). The expression levels were normalized by using Gapdh as 
an internal control. Data are expressed as mean ± SEM (n=3). (B) Pairs of representative photos 
showing the development of preimplantation embryos injected with either siSmyd3-2 or siControl. 
Embryos were photographed at 36 h after in vitro fertilization and 24 h intervals thereafter. (C) The 
percentage of development at E1.5 (≥ 2-cell), E2.5 (≥ 4-cell), E3.5 (≥ morula), E4.5 (≥ blastocyst), 
and E5.5 (≥ hatching) in embryos injected with either siSmyd3-2 or siControl. Data are expressed as 
mean ± SEM (n=3). Twenty to 30 embryos were used in each experiment (75 and 88 embryos in 
total in siControl and siSmyd3-2, respectively). 
 
Supplementary Figure 2. The effects of siSmyd3-2 injection on the expression of Oct4 and Cdx2. 
(A) qRT-PCR analysis of the early-lineage markers Oct4 and Cdx2 in blastocyst embryos injected 




Gapdh as an internal control. Data are expressed as mean ± SEM (n=3). (B) Immunostaining of 
OCT4 and CDX2 in blastocyst embryos injected with either siSmyd3-2 or siControl (OCT4, red; 
CDX2, green; chromatin, blue). 
 
Supplementary Figure 3.  Knockdown of Smyd3 influence the levels of OCT4 and CDX2 
proteins not the levels of H3K4me3. 
(A) Immunoblot analysis of OCT4, CDX2, H3K4me3, and α-TUBULIN in Smyd3-knockdown and 
control blastocyst embryos. (B) Immunostaining of H3K4me3 in Smyd3-knockdown and control 





 Table 1. Effect of Smyd3-knockdown on mouse embryo development. 
  






No. live offspring 
(mean ± SEM) 
% live 
offspring 
siControl 4 60a 4 31 (7.8±0.25) 51.7b 
siSmyd3-1 4 60a 4 12 (3.0±0.41) 20.0c 
a Fifteen embryos were transferred to each recipient at the trial. 
b, c p < 0.05 









